Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/24 16:24 | 12/18/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Dulac Edward J III | CA | O | CFO | 7 | S | -122 | 4.35 | 0 | -28 | 124 | D | |||||||||||||||
1/10/24 16:30 | 11/9/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Tahl Cindy | CA | O | GC,Secre | 2 | S | -106 | 3.01 | 0 | -35 | 153 | D | |||||||||||||||
1/10/24 16:30 | 1/9/24 | FATE | Health | BioPrd | Biological Products, (No Diag | Valamehr Bahram | CA | O | Chief R, | 1 | S | -49 | 4.38 | 0 | -11 | 158 | D | |||||||||||||||
1/10/24 16:29 | 1/9/24 | FATE | Health | BioPrd | Biological Products, (No Diag | Wolchko J Scott | CA | DO | P,CEO | 1 | S | -63 | 4.37 | 0 | -14 | 371 | D | |||||||||||||||
8/7/23 16:01 | 8/4/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Xu Yuan | CA | D | 2 | S | -22 | 5.29 | 0 | -4 | 10 | D | ||||||||||||||||
7/6/23 17:19 | 7/5/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Powl Brian T. | CA | O | Chief Co | 1 | S | -19 | 4.87 | 0 | -4 | 41 | D | |||||||||||||||
4/19/23 16:07 | 4/18/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Chu Yu-Waye | CA | O | Chief Me | 1 | S | -17 | 6.58 | 0 | -3 | 141 | D | |||||||||||||||
4/17/23 21:30 | 4/14/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | 1 | S.d | -1,766 | 5.84 | 0 | -302 | 12,859 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |